Inovalon (NASDAQ:INOV) issued an update on its FY19 earnings guidance on Wednesday morning. The company provided EPS guidance of $0.41-0.47 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.43. The company issued revenue guidance of $637-657 million, compared to the consensus revenue estimate of $647.06 million.Inovalon also updated its FY 2018 guidance to $0.27-0.34 EPS.
INOV traded down $0.09 during midday trading on Wednesday, hitting $10.08. The company had a trading volume of 356,478 shares, compared to its average volume of 525,747. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 1.38. The stock has a market capitalization of $1.43 billion, a PE ratio of 43.83, a PEG ratio of 2.38 and a beta of 1.02. Inovalon has a twelve month low of $8.90 and a twelve month high of $16.90.
Several equities research analysts have weighed in on INOV shares. BidaskClub upgraded shares of Inovalon from a hold rating to a buy rating in a research report on Saturday, October 13th. ValuEngine cut shares of Inovalon from a hold rating to a sell rating in a research report on Tuesday, September 4th. Finally, Zacks Investment Research upgraded shares of Inovalon from a hold rating to a strong-buy rating and set a $14.00 price objective for the company in a research report on Tuesday, August 7th. One equities research analyst has rated the stock with a sell rating and four have given a hold rating to the company. The stock has a consensus rating of Hold and an average target price of $11.67.
Inovalon Holdings, Inc, a technology company, provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models in the healthcare industry. The company's platform enables the assessment and enhancement of clinical and quality outcomes and financial performance.
Featured Article: Do closed-end mutual funds pay dividends?
Receive News & Ratings for Inovalon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon and related companies with MarketBeat.com's FREE daily email newsletter.